6092
EnBio Holdings,Inc
エンバイオ・ホールディングス
- Industry
- Services
- Market
- Standard
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2022
8,988
Mar 2023
8,120
Mar 2024
9,576
Mar 2025
10,668
Mar 2026
12,630
Operating profit(million JPY)
Mar 2022
1,229
Mar 2023
1,357
Mar 2024
815
Mar 2025
839
Mar 2026
1,619
Operating profit margin(%)
Mar 2022
13.68
Mar 2023
16.72
Mar 2024
8.51
Mar 2025
7.87
Mar 2026
12.82
Profit before tax(million JPY)
Mar 2022
1,099
Mar 2023
1,233
Mar 2024
1,066
Mar 2025
702
Mar 2026
915
Profit(million JPY)
Mar 2022
654
Mar 2023
812
Mar 2024
709
Mar 2025
453
Mar 2026
265
Total assets(million JPY)
Mar 2022
16,370
Mar 2023
17,350
Mar 2024
19,311
Mar 2025
21,195
Mar 2026
22,848
Cash and cash equivalents(million JPY)
Mar 2022
2,342
Mar 2023
2,799
Mar 2024
3,574
Mar 2025
3,263
Mar 2026
4,006
Cash flows from operating activities(million JPY)
Mar 2022
2,413
Mar 2023
1,989
Mar 2024
1,663
Mar 2025
22
Mar 2026
1,167
Cash flows from investing activities(million JPY)
Mar 2022
-1,481
Mar 2023
-1,770
Mar 2024
-1,584
Mar 2025
-1,603
Mar 2026
-895
Cash flows from financing activities(million JPY)
Mar 2022
-535
Mar 2023
241
Mar 2024
639
Mar 2025
1,274
Mar 2026
464
Return on equity(%)
Mar 2022
11.7
Mar 2023
12.8
Mar 2024
9.3
Mar 2025
5.1
Mar 2026
2.9
Equity ratio(%)
Mar 2022
36
Mar 2023
39.1
Mar 2024
44
Mar 2025
43.1
Mar 2026
40.5
Earnings per share(JPY per share)
Mar 2022
98.52
Mar 2023
122.27
Mar 2024
88.85
Mar 2025
55.9
Mar 2026
32.73
Net assets per share(JPY per share)
Mar 2022
886.12
Mar 2023
1,022.7
Mar 2024
1,043.91
Mar 2025
1,128.81
Mar 2026
1,139.31
Dividend per share(JPY per share)
Mar 2022
8
Mar 2023
8
Mar 2024
8
Mar 2025
9
Mar 2026
9
Payout ratio(%)
Mar 2022
8.12
Mar 2023
6.54
Mar 2024
9
Mar 2025
16.1
Mar 2026
27.5
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.